Are Sirius Minerals and CloudTag top buys after this month’s financing deals?

Should you load up on Sirius Minerals and CloudTag today?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Popular AIM stocks Sirius Minerals (LSE: SXX) and CloudTag (LSE: CTAG) have both announced financing deals this month. But with their shares currently trading well below previous highs, is now the time for canny investors to buy a slice of these two businesses?

Sirius on track

Sirius is set to begin construction of its North Yorkshire potash mine having announced comprehensive funding for Stage 1 of its two-stage funding requirement.

Back in the summer, at a share price of 26.5p and market cap of £611m, I reckoned the equity component of the funding would be around £400m, giving a prospective market cap of just over £1bn. I rated the stock a speculative buy based on the £1bn valuation and projected annual revenues of $3bn (£2.4bn).

The equity component has turned out to be £370m via a placing and open offer at 20p. But there’s also a future $50m share issue at 20p (part of a $300m royalty financing deal with Australian mining magnate Gina Rinehart) and a $400m convertible bond issue with a conversion price of 25p.

Taking all this into account, the prospective diluted market cap is about £1.2bn at a current share price of 21p. So, the funding has been somewhat more generous to the new investors than I envisaged. However, risk has reduced through securing the Stage 1 funding, Stage 2 is expected to be via senior debt and a valuation of 0.5 times projected annual revenues offers some protection against any unexpected further equity dilution before first production in 2021. As such, I continue to believe the stock is an attractive buy.

CloudTag off track

Wearable technology firm CloudTag (LSE: CTAG) started 2016 with a bang, announcing the launch of its first product (a fitness tracker) and a commercial contract with distributor Second Chance that would “guarantee” minimum sales of $5.2m by year-end.

In early June, CloudTag said Second Chance “is now concluding initial product delivery requirements” with 11 retailers — unnamed but in most cases readily identifiable: for example, “the largest employee-owned UK department store” (John Lewis) and “Europe’s largest retailer for consumer electronics, with over 700 Stores in 14 countries” (Media Markt).

On 7 November, CloudTag announced that “no firm purchase orders have as yet been received from Second Chance or otherwise” and that the minimum $5.2m of orders by year-end “is now unlikely to be achieved”.

In the same announcement, CloudTag said it intended to raise £4m by issuing convertible notes to “an overseas Institutional Investor.” In contrast to Sirius’s conventional convertibles issue — in which conversion is based on a fixed price — CloudTag’s is based on a fluctuating market price. Indeed, CloudTag’s deal has several hallmarks of what, in the words of the US Securities & Exchange Commission, “have colloquially been called ‘floorless’, ‘toxic,’ ‘death spiral,’ and ‘ratchet’ convertibles”. Such deals are rarely good news for shareholders.

At a price of 11.2p in early trading today and with 379,295,962 shares in issue, CloudTag has a market cap of £42m. The company isn’t short of enthusiastic supporters but for me this is a stock to avoid due to:

  • The ‘guaranteed’ sales that weren’t in truth guaranteed.
  • The lack of a single firm order more than 10 months after commercial launch and five months after Second Chance was “now concluding” initial orders with multiple major retailers.
  • The low-grade financing deal.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Up 50% in a year! Now check out the intriguing BP share price forecast for the next 12 months

The BP share price is up one day, down the next, as geopolitical uncertainty rattles the FTSE 100. Harvey Jones…

Read more »

Investing Articles

Is now the perfect time to buy high-yield FTSE 100 dividend shares? 

Harvey Jones says UK dividend shares have a brilliant track record of delivering income and growth, and he can see…

Read more »

Bronze bull and bear figurines
Investing Articles

At 7,000 points, the S&P 500 looks bloated. How should investors navigate this market?

AI-hype may have ballooned the S&P 500 into the mother of all bubbles – but only time will tell. For…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

How £100 can start a portfolio of UK stocks

Whether it’s building wealth or earning passive income, UK investors might be surprised at what £100 a month in stocks…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

How £16,000 can generate a second income in a Stocks and Shares ISA

Stephen Wright explains how UK investors can target an immediate £1,224 annual second income from UK dividend shares with a…

Read more »

Bronze bull and bear figurines
Investing Articles

This crazy growth stock is up 97% inside 2 months in my ISA!

Hims & Hers Health (NYSE:HIMS) is both an exciting and incredibly volatile growth stock. What on earth has sent it…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

How to target a million-pound SIPP by investing in UK shares

Harvey Jones shows how investors could target a SIPP worth a life-changing seven-figure sum, by investing in FTSE 100 dividend…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

Buying £20k of BAE Systems shares could give me a £360 income this year!

Looking for the best dividend stocks out there? Royston Wild explains why BAE Systems shares are worth considering.

Read more »